A systematic review and meta-analysis of clinical variables used in Huntington disease research

Movement Disorders

Volumn 28, Issue 14, 2013, Pages 1987-1994

  Franciosi, Sonia ^a   Shim, Yaein ^a   Lau, Margaret ^a   Hayden, Michael R ^a   Leavitt, Blair R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Clinical endpoint; Disease severity; Huntington disease; Literature; Meta analysis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN;

AGGRESSION; APATHY; ARTICLE; BLOOD; BODY MASS; CEREBROSPINAL FLUID; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); DATA BASE; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; EXECUTIVE FUNCTION; HUMAN; HUNTINGTON CHOREA; LONGITUDINAL STUDY; MEDICAL LITERATURE; META ANALYSIS; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; OUTCOME ASSESSMENT; PLASMA; PRIORITY JOURNAL; RATING SCALE; STROOP TEST; SYMPTOM CHECKLIST 90; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNIFIED HUNTINGTON DISEASE RATING SCALE; VERBAL COMMUNICATION; WISCONSIN CARD SORTING TEST;

CLINICAL ENDPOINT; DISEASE SEVERITY; HUNTINGTON DISEASE; LITERATURE; META-ANALYSIS;

BIOMEDICAL RESEARCH; DATABASES, BIBLIOGRAPHIC; HUMANS; HUNTINGTON DISEASE;

EID: 84889648174     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25663     Document Type: Article

References (17)

1. Paulsen JS, Langbehn DR, Stout JC, et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J Neurol Neurosurg Psychiatry 2008;79:874-880.
2. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
3. de Boo G, Tibben A, Hermans J, et al. Subtle involuntary movements are not reliable indicators of incipient Huntington's disease. Mov Disord 1998;13:96-99.
4. Paulsen JS, Hayden M, Stout JC, et al. Preparing for preventive clinical trials: the Predict-HD study. Arch Neurol 2006;63:883-890.
5. Tabrizi SJ, Langbehn DR, Leavitt BR, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009;8:791-801.
6. Weir DW, Sturrock A, Leavitt BR. Development of biomarkers for Huntington's disease. Lancet Neurol 2011;10:573-590.
7. Tabrizi SJ, Reilmann R, Roos RA, et al. Potential endpoints for clinical trials in pre-manifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 2012;11:42-53.
8. Shoulson I, Fahn S. Huntington's disease: clinical care and evaluation. Neurology 1979;29:1-3.
9. Langbehn DR, Brinkman RR, Falush D, et al. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004;65:267-277.
10. Tabrizi SJ, Scahil R, Durr A, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. Lancet Neurol 2011;10:31-42.
11. Hedges LV, Vevea, JL. Fixed- and random-effects models in meta-analysis. Psychol Methods 1998;3:486-504.
12. Biglan KM, Ross CA, Langbehn DR, et al. Motor abnormalities in pre-manifest persons with Huntington's disaese: The Predict-HD Study. Mov Disord 2009;24:1763-1772.
13. Paulsen JS, Wang C, Duff K, et al. Challenges assessing clinical endpoints in early Huntington disease. Mov Disord 2010;25:2595-2603.
14. Bechtel N, Scahill RI, Rosas HD, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology 2010;75:2150-2160.
15. Micheel CM, Ball JR, eds. Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Institute of Medicine Consensus Report. Washington, DC: National Academies Press; 2010:108-109.
16. Kieburtz K, Venuto C. TRACK-HD: both promise and disappointment. Lancet Neurol 2012;11:24-25.
17. Henley SM, Ridgway GR, Scahill RI, et al. Pitfalls in the use of voxel-based morphometry as a biomarker: examples from Huntington disease. Am J Neuroradiol 2010;31:711-719.